Trademark: 79326219
Status Date
Tuesday, March 28, 2023
Registration Number
7008451
Registration Date
Tuesday, March 28, 2023
Filing Date
Monday, September 27, 2021
Published for Opposition
Tuesday, January 10, 2023
9 Downloadable software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software platforms using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
42 Software as a service (SaaS) services featuring software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; software as a service (SaaS) services featuring artificial intelligence software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; platform as a service (PaaS) services featuring software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; platform as a service (PaaS) services featuring software platforms using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; conducting clinical trials for others of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Aug 7, 2023
Final Decision Transaction Processed By Ib
Jul 18, 2023
Final Disposition Notice Sent To Ib
Jul 18, 2023
Final Disposition Processed
Jun 28, 2023
Final Disposition Notice Created, To Be Sent To Ib
Mar 28, 2023
Notice Of Registration Confirmation Emailed
Mar 28, 2023
Registered-Principal Register
Jan 24, 2023
Notification Processed By Ib
Jan 10, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 10, 2023
Published For Opposition
Jan 4, 2023
Notification Of Possible Opposition Sent To Ib
Jan 4, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 21, 2022
Notification Of Notice Of Publication E-Mailed
Dec 2, 2022
Approved For Pub - Principal Register
Nov 17, 2022
Teas/Email Correspondence Entered
Nov 16, 2022
Correspondence Received In Law Office
Nov 16, 2022
Teas Response To Office Action Received
Oct 19, 2022
Limitation From The Ib Examined, No Action Is Needed
Oct 6, 2022
Attorney Review Completed
Oct 6, 2022
Limitation From The Ib - Request Exam Review
Aug 23, 2022
Refusal Processed By Ib
Jul 29, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 29, 2022
Refusal Processed By Mpu
Jul 3, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 2, 2022
Non-Final Action Written
Jun 28, 2022
Assigned To Examiner
Jun 20, 2022
Limitation Of Goods Received From Ib
May 29, 2022
Limitation Of Goods Received From Ib
Nov 23, 2021
Application Filing Receipt Mailed
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 18, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
